Authorization of the Bonds. The Bonds to be purchased by the Underwriters from the Company are in the form contemplated by the Mortgage Indenture, have been duly authorized for issuance and sale pursuant to this Agreement and the Mortgage Indenture and, at the Closing Date, will have been duly executed by the Company and, when authenticated in the manner provided for in the Mortgage Indenture and delivered against payment of the purchase price therefor, will be validly issued and delivered and will constitute valid and binding obligations of the Company, enforceable in accordance with their terms, except as the enforcement thereof may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws relating to or affecting enforcement of mortgagees’ or other creditors’ rights generally and except as enforcement thereof is subject to general principles of equity (regardless of whether enforcement is considered in a proceeding in equity or at law) and will be entitled to the benefits of the Mortgage Indenture.
Authorization of the Bonds. (A) For the purposes provided herein, Bonds of the Trust are hereby authorized to be issued from time to time in one or more Series without limitation as to amount except as provided in this Trust Agreement or as may be limited by law. All such Bonds shall be entitled “State Revolving Fund Bonds” and may be further designated either as “Senior” or as “Subordinate” and may also be further designated as set forth in the applicable Supplemental Resolution. The Bonds may, if and when authorized by the Trust pursuant to one or more Supplemental Trust Agreements, be issued in one or more Series, and the designation thereof may include such further or alternate appropriate designations added to or incorporated in such title for the Bonds of any particular Series as the Trust may determine. The Bonds shall not be general obligations of the Trust or a pledge of its full faith and credit, but shall be special obligations of the Trust secured solely as provided herein and payable solely from the funds, amounts and other rights and property available and pledged to such payments pursuant to Section 5.1 of this Trust Agreement and the applicable Supplemental Trust Agreement. The Bonds may be issued as Fixed Rate Bonds, Variable Rate Bonds, Tender Bonds, Capital Appreciation Bonds, Deferred Income Bonds or Discount Bonds or any combination thereof in accordance with applicable provisions set forth below and the applicable Supplemental Trust Agreement.
Authorization of the Bonds. The Bonds have been duly authorized and, at the Closing Time, will have been duly executed by the Company and, when authenticated, issued and delivered in the manner provided for in the First Mortgage Indenture, will constitute valid and binding obligations of the Company, enforceable against the Company in accordance with their terms, except as the enforcement thereof may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting enforcement of creditors' rights generally and except as enforcement thereof is subject to general principles of equity (regardless of whether enforcement is considered in a proceeding in equity or at law), and will be in the form contemplated by, and secured by the lien of and entitled to the benefits provided by, the First Mortgage Indenture.
Authorization of the Bonds. The Company has authorized the issue and sale of $150,000,000 aggregate principal amount of its First Mortgage Bonds consisting of (a) $50,000,000 aggregate principal amount of its First Mortgage Bonds, 6.15% Series A Due May 15, 2023 (the “Series A Bonds”) and (b) $100,000,000 aggregate principal amount of its First Mortgage Bonds, 6.64% Series B Due May 15, 2038 (the “Series B Bonds”). The Series A Bonds and the Series B Bonds are herein collectively referred to as the “Bonds”. The term “Bonds” shall include any such bonds issued in substitution therefor pursuant to the terms and provisions of the Supplemental Indenture (as hereinafter defined) and the Indenture (as hereinafter defined). The Series A Bonds and the Series B Bonds shall be substantially in the form set out in the Supplemental Indenture, with such changes therefrom, if any, as may be approved by the Purchasers and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B to this Agreement; and references to a “Schedule” or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.
Authorization of the Bonds. The Company has duly authorized to issue and sell the Bonds on December 31, 2019 KST or such other date as may be agreed between the Company and the Investor (the “Issue Date”), pursuant to the terms and conditions as set forth herein.
Authorization of the Bonds. The Authority hereby authorizes the issuance of two Bonds to be designated (a) Economic Development Bond (Immunomedics, Inc. Project) Series 2003 A in a principal amount of $1,000,000, and (b) Economic Development Bond (Immunomedics, Inc. Project) Series 2003 B (Federally Taxable) in a principal amount of $5,376,000, in order to make the Loan. The Bond shall be a special and limited obligation of the Authority payable solely from amounts in the Funds and Accounts held under the Loan Documents.
Authorization of the Bonds. 6 (xiii) DESCRIPTION OF THE SENIOR NOTES, [THE BONDS,] THE INDENTURE [AND THE FIRST MORTGAGE INDENTURE]. . . . . . . . . . . . . . . . . . . 6 (xiv)
Authorization of the Bonds. The Issuer has duly authorized the issuance and sale of $17,200,000 in principal amount of its Revenue Bonds (Sxxxxxxxx Farms, Inc. (Production Division) Project), Series 2006 (the “Bonds,” such term to include any such Bonds issued in substitution therefor pursuant to Section 10 of this Agreement). The Bonds shall be substantially in the form set out in Exhibit A, with such changes therefrom, if any, as may be approved by you and the Issuer. Certain capitalized terms used in this Agreement are defined in Section 15 of this Agreement; references to an “Exhibit” are, unless otherwise specified, to an Exhibit attached to this Agreement. Capitalized terms not otherwise defined herein shall be defined as forth in the Lease Agreement of even date (the “Lease Agreement”) between the Issuer and Sxxxxxxxx Farms, Inc. (Production Division) (the “Lessee”), a Mississippi corporation.
Authorization of the Bonds. The Company has authorized the issue and sale of $175,000,000 aggregate principal amount of its First Mortgage Bonds, 6.53% Series Due December 15, 2037 (the “Bonds”). The term “Bonds” shall include any such bonds issued in substitution therefor pursuant to the terms and provisions of the Supplemental Indenture (as hereinafter defined) and the Indenture (as hereinafter defined). The Bonds shall be substantially in the form set out in the Supplemental Indenture, with such changes therefrom, if any, as may be approved by you and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule A to this Agreement; and references to a “Schedule” or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.
Authorization of the Bonds. (a) There shall be issued and secured by this Indenture a series of Bonds in the aggregate maximum principal amount of $24,500,000 for the purpose of providing funds for paying the costs of the Project, which Bonds shall be designated "City of Olathe, Kansas Industrial Revenue Bonds (PacSun Project), Series 2007." The Bonds shall be dated as provided in SECTION 203(b) hereof, shall become due on January 1, 2018 (subject to prior redemption as hereinafter provided in ARTICLE III) and shall bear interest as specified in SECTION 208(e) hereof, payable on the dates specified in SECTION 208(e) hereof.
